Given this risk, we thought we'd take a look at whether CRISPR Therapeutics (NASDAQ:CRSP) shareholders should be worried ...

In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $48.51, indicating a -0.84% shift from the previous trading day.

Longer Term Trading Plans for CRSP. Buy CRSP near 40.82 target 52.08 stop loss @ 40.7 Details; The technical summary data ...

EDT Cathie Wood’s ARK Investment bought 47.8K shares of Crispr Therapeutics (CRSP) today Published first on TheFly – the ...

In a report released today, Joon Lee from Truist Financial reiterated a Buy rating on Crispr Therapeutics AG (CRSP – Research Report).

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other promising biotech stocks. Biotechnology stocks are known for their high risk ...

In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other promising biotech stocks. Biotechnology stocks are known for their high risk, making ...

NASDAQ:CRSP opened at $49.00 on Monday. The company’s fifty day moving average price is $47.14 and its 200-day moving average price is $53.59. CRISPR Therapeutics has a 1-year low of $37.55 and ...

View Our Latest Research Report on CRISPR Therapeutics CRISPR Therapeutics Price Performance Shares of CRSP stock opened at $48.92 on Friday. The company has a market cap of $4.15 billion, a PE ...